Lethal brain tumour shields itself from immune attack

by Hayley Jarvis,Brunel UniversityGBM cells can be highly invasive in the brain, or fast growing while being localised. Credit: Dr SK Singh, Gottingen Medical Centre, GermanyOne of the deadliest

Updated on: March 01,2024

Lethal brain tumour shields itself from immune attack

by Hayley Jarvis,Brunel UniversityGBM cells can be highly invasive in the brain, or fast growing while being localised. Credit: Dr SK Singh, Gottingen Medical Centre, GermanyOne of the deadliest

Updated on:March 01,2024

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo

Updated on: March 06,2024

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo

Updated on:March 06,2024

EU approves treatment for prostate cancer

Prostate cancer cells. Credit: NIH Image GalleryThe European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.The

Updated on: January 02,2024

EU approves treatment for prostate cancer

Prostate cancer cells. Credit: NIH Image GalleryThe European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.The

Updated on:January 02,2024

Study reveals inequities in access to CAR T cell therapy

by Meagan Raeke,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainPatients being treated for B-cell non-Hodgkin's Lymphoma (NHL) who are part of minority

Updated on: March 30,2024

Study reveals inequities in access to CAR T cell therapy

by Meagan Raeke,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainPatients being treated for B-cell non-Hodgkin's Lymphoma (NHL) who are part of minority

Updated on:March 30,2024

Pretherapy imaging and dosimetry offer personalized treatment planning for thyroid cancer patients

by Society of Nuclear MedicineExample of whole-body planar scans at 24 hours after123I-NaI administration at baseline, before selumetinib was administered (A), and after 4 weeks of treatmen

Updated on: February 01,2024

Pretherapy imaging and dosimetry offer personalized treatment planning for thyroid cancer patients

by Society of Nuclear MedicineExample of whole-body planar scans at 24 hours after123I-NaI administration at baseline, before selumetinib was administered (A), and after 4 weeks of treatmen

Updated on:February 01,2024

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe

Updated on: January 12,2024

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe

Updated on:January 12,2024

Research finds genes associated with most aggressive kidney cancer

by Ekaterina Korchagina, National Research University Higher School of EconomicsIdentification of marker genes for Cluster 1 and Cluster 2 (a) using the rank sum test. Scheme of PPI taking into accoun

Updated on: February 03,2024

Research finds genes associated with most aggressive kidney cancer

by Ekaterina Korchagina, National Research University Higher School of EconomicsIdentification of marker genes for Cluster 1 and Cluster 2 (a) using the rank sum test. Scheme of PPI taking into accoun

Updated on:February 03,2024

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on: February 03,2024

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on:February 03,2024

Remote telemedicine tool found highly accurate in diagnosing melanoma

byNYU Langone HealthResearchers believe that using telemedicine for dermatology may also help avoid trips to specialists for lesions that turn out to be benign. Credit: Haley RicciardiCollecting

Updated on: November 30,2024

Remote telemedicine tool found highly accurate in diagnosing melanoma

byNYU Langone HealthResearchers believe that using telemedicine for dermatology may also help avoid trips to specialists for lesions that turn out to be benign. Credit: Haley RicciardiCollecting

Updated on:November 30,2024

Ewing sarcoma tumors can be split into two groups for targeted care

by Cincinnati Children's Hospital Medical CenterA. Bright field images of CCH1 and CCH2 cells B. CCH1 and CCH2 cells cells stained with antibody towards CD99 (green) and DAPI (blue) C. Wester

Updated on: February 03,2024

Ewing sarcoma tumors can be split into two groups for targeted care

by Cincinnati Children's Hospital Medical CenterA. Bright field images of CCH1 and CCH2 cells B. CCH1 and CCH2 cells cells stained with antibody towards CD99 (green) and DAPI (blue) C. Wester

Updated on:February 03,2024

Study finds providers use prostate cancer screening tests, even when they provide little value to patients

byWake Forest University Baptist Medical CenterChris Gillette, Ph.D., associate professor of PA Studies for Wake Forest University School of Medicine, collaborates with colleagues. Credit: Wake

Updated on: January 23,2024

Study finds providers use prostate cancer screening tests, even when they provide little value to patients

byWake Forest University Baptist Medical CenterChris Gillette, Ph.D., associate professor of PA Studies for Wake Forest University School of Medicine, collaborates with colleagues. Credit: Wake

Updated on:January 23,2024

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu

Updated on: January 30,2024

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu

Updated on:January 30,2024